Pancreatic cancer cells survive in the neural niche during neoadjuvant therapy

Sadeleştirilmiş öğe sayfası
dc.contributor.authorCifcibasi, Kaan
dc.contributor.authorGoess, Ruediger
dc.contributor.authorMunkhbaatar, Enkhtsetseg
dc.contributor.authorPergolini, Ilaria
dc.contributor.authorJaeger, Carsten
dc.contributor.authorMuckenhuber, Alexander
dc.contributor.authorFriess, Helmut
dc.contributor.authorCeyhan, Gueralp Onur
dc.contributor.authorIstvanffy, Rouzanna
dc.contributor.authorDemir, Ihsan Ekin
dc.contributor.authorReyes, Carmen Mota
dc.date.accessioned2025-10-16T15:11:29Z
dc.date.issued2025
dc.identifier.doi10.1016/j.canlet.2025.217894
dc.identifier.otherWOS:001524559400002
dc.identifier.urihttps://openaccess.acibadem.edu.tr/handle/11443/4722
dc.publisherELSEVIER IRELAND LTD
dc.sourceCANCER LETTERS
dc.subjectPancreatic cancer
dc.subjectNeural invasion
dc.subjectNeoadjuvant therapy
dc.subjectNerves
dc.subjectTherapy resistance
dc.titlePancreatic cancer cells survive in the neural niche during neoadjuvant therapy
dc.typeArticle

Dosyalar

Koleksiyonlar

WOS